Evaluation of the oxidant and antioxidant balance in the pathogenesis of Chronic Obstructive Pulmonary Disease;Avaliação do equilíbrio entre oxidantes e antioxidantes na patogénese da doença pulmonar obstrutiva crónica

Revista Portuguesa de Pneumologia

Volumn 19, Issue 2, 2013, Pages 70-75

  Cristovao C ^a   Cristovao L ^b,c,d   Nogueira, F ^a   Bicho, M ^d  

^a HOSPITAL EGAS MONIZ   (Portugal)

^b UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Antioxidants; Chronic obstructive pulmonary disease; Lipid peroxidation; Oxidative stress

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; MALONALDEHYDE; OXIDIZING AGENT;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; HUMAN; LIPID PEROXIDATION; OXIDATIVE STRESS; PATHOGENESIS;

AGED; FEMALE; HUMANS; MALE; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84876716491     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rppneu.2012.09.002     Document Type: Article

References (35)

1. Repine J.E., Bast A., Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997, 156:341-357. Oxidative Stress Study Group.
2. Tuder R.M., Voelkel N.F. The pathobiology of chronic bronchitis and emphysema. Chronic Obstructive Lung Diseases 2002, 90-113. BC Decker Inc. N.F. Voelkel, W. MacNee (Eds.).
3. Vestbo J. Epidemiology. Chronic Obstructive Lung Diseases 2002, 41-55. BC Decker Inc. N.F. Voelkel, W. MacNee (Eds.).
4. Rahman I., MacNee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease. Thorax 1996, 51:348-350.
5. MacNee W., Rahman I. Oxidants and antioxidants as therapeutic targets in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:S58-S65.
6. MacNee W. Oxidants/Antioxidants and COPD. CHEST 2000, 117:303S-317S.
7. Hanta I., Kocabas A., Canacankatan N., Kuleci S., Seydaoglu G. Oxidant-antioxidant balance in patients with COPD. Lung 2006, 184:51-55.
8. Park H.S., Kim S.R., Lee Y.C. Impact of oxidative stress on lung diseases. Respirology 2009, 14:27-38.
9. Langen R.C.J., Korn S.H., Wouters E.F.M. ROS in the local and systemic pathogenesis of COPD. Free Radic Biol Med 2003, 35:226-235.
10. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:258-266.
11. Dourado V.Z., Tanni S.E., Vale S.A., Faganello M.M., Sanchez F.F., Godoy I. Systemic manifestations in chronic obstructive pulmonary disease. J Bras Pneumol 2006, 32:161-171.
12. Fischer B.M., Pavlisko E., Voynow J.A. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis 2011, 6:413-421.
13. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005, 2:50-60.
14. Kluchová Z., Petrásova D., Joppa P., Dorková Z., Tkácová R. The association between oxidative stress and obstructive lung impairment in patients with COPD. Phys Res 2007, 56:51-56.
15. Mak J.C.W. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis 2008, 12:368-374.
16. Gutteridge J.M.C. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 41:1819-1828.
17. Bartoli M.L., Novelli F., Costa F., Malagrinò L., Melosini L., Bacci E., et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm 2011, 1-6.
18. Rueff J., Laires A., Brás A., Borba H., Chaveca T., Gaspar J., et al. DNA damage and oxygen species. DNA repair mechanisms and their biological implications in mammalian cells 1989, Plenum Press, New York, p. 171-81.
19. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesselin G., Wouters E.F.M. Systemic effects of smoking. Chest 2007, 131:1557-1566.
20. Veskoukis A.S., Nikolaidis M.G., Kyparos A., Kouretas D. Blood reflects tissue oxidative stress depending on biomarker and tissue studied. Free Rad Bol Med 2009, 47:1371-1374.
21. Rahman I., Swarska E., Henry M., Stolk J., MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?. Thorax 2000, 55:189-193.
22. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
23. Omaye S.T., Turnbull J.D., Sauberlich H.E. Selected methods for determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol, Vitamins and Coenzymes 1979, 3-11. Academic Press, New York. D.B. McCormick, L.D. Wrigth (Eds.).
24. Rice-Evans C., Diplock A., Symons C. Techniques in Free Radical Research. Laboratory techniques in biochemistry and molecular biology 1991, 227-229. Elsevier. R.H. Burdon, P.H. Knippenberg (Eds.).
25. Rahman I., van Schadewijk A.A.M., Crowther A.J.L., Hiemstra P.S., Stolk J., MacNee W., et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002, 166:490-495.
26. Nowak D., Kasielski M., Antczak A., Pietras T., Bialasiewicz P. Increased content of thiobarbituric acid-reactive substances and hydrogen peroxide in the expired breath condensate of patients with stable chronic obstructive pulmonary disease: no significant effect of cigarette smoking. Respir Med 1999, 93:389-396.
27. Cross C.E., O'Neill C.A., Reznick A.Z., Hu M.L., Marcocci L., Packer L., et al. Cigarette smoke oxidation of human plasma constituents. Ann N Y Acad Sci 1993, 686:72-90.
28. Rahman I., Morrison D., Donaldson K., MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Med 1996, 154:1055-1060.
29. Agacdiken A., Basyigit I., Özden M., Yildiz F., Ural D., Maral H., et al. The effects of antioxidants on exercise-induced lipid peroxidation in patients with COPD. Respirology 2004, 9:38-42.
30. Nadeem A., Raj H.G., Chhabra S.K. Increased oxidative stress and altered levels of antioxidants in chronic obstructive pulmonary disease. Inflammation 2005, 29:23-32.
31. Foronjy R., Wallace A., d'Armiento J. The pharmokinetic limitations of antioxidant treatment for COPD. Pulm Pharmacol Ther 2008, 21:370-379.
32. Rahman I. Antioxidant therapeutic advances in COPD. Ther Adv Respir Dis 2008, 2:351-374.
33. Gould N.S., Min E., Gauthier S., Chu H.W., Martin R., Day B.J. Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung. Am J Resp Crit Care Med 2010, 182:1114-1122.
34. Bridges A.B., Scott N.A., Parry G.J., Belch J.J. Age, sex, cigarette smoking and indices of free radical activity in healthy humans. Eur J Med 1993, 2:205-208.
35. Block G., Dietrich M., Norkus E.P., Morrow J.D., Hudes M., Caan B., et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002, 156:274-285.